Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Luque Fernandez, Miguel Angel ^a,e   Van Cutsem, Gilles ^a,b   Goemaere, Eric ^a,b   Hilderbrand, Katherine ^a,b   Schomaker, Michael ^a   Mantangana, Nompumelelo ^c   Mathee, Shaheed ^c   Dubula, Vuyiseka ^d   Ford, Nathan ^a,b   Hernán, Miguel A ^e,f   Boulle, Andrew ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c WESTERN CAPE DEPARTMENT OF AGRICULTURE   (South Africa)

^d Treatment Action Campaign   (South Africa)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENTION TO TREAT ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT PARTICIPATION; REBOUND; SOUTH AFRICA; TRADITIONAL MEDICINE; TREATMENT DURATION;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DELIVERY OF HEALTH CARE; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; RECURRENCE; SOUTH AFRICA; VIRAL LOAD; YOUNG ADULT;

EID: 84873885939     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056088     Document Type: Article

References (30)

1. Organization WH. World Health Statistics 2011. Geneva: World Health Organization; (171 p.) Available: http://www.who.int/gho/publications/world_health_statistics/2011/en/index.html. Accesed: 2 December 2011.
2. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. Aids 24: 2263-2270.
3. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, et al. (2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 24: 563-572.
4. Bedelu M, Ford N, Hilderbrand K, Reuter H, (2007) Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. The Journal of infectious diseases 196Suppl 3: S464-468.
5. Bemelmans M, Van Den Akker T, Ford N, Philips M, Zachariah R, et al. (2010) Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Tropical medicine & international health: TM & IH 15: 1413-1420.
6. Cohen R, Lynch S, Bygrave H, Eggers E, Vlahakis N, et al. (2009) Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. Journal of the International AIDS Society 12: 23.
7. Decroo T, Telfer B, Biot M, Maikere J, Dezembro S, et al. (2010) Distribution of antiretroviral treatment through self-forming groups of patients in Tete province, Mozambique. Journal of acquired immune deficiency syndromes.
8. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, et al. (2009) Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 374: 2080-2089.
9. Massaquoi M, Zachariah R, Manzi M, Pasulani O, Misindi D, et al. (2009) Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 103: 594-600.
10. Nabudere H, Asiimwe D, Mijumbi R, (2011) Task shifting in maternal and child health care: an evidence brief for Uganda. International journal of technology assessment in health care 27: 173-179.
11. Sanne I, Orrell C, Fox MP, Conradie F, Ive P, et al. (2010) Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet 376: 33-40.
12. Selke HM, Kimaiyo S, Sidle JE, Vedanthan R, Tierney WM, et al. (2010) Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. Journal of acquired immune deficiency syndromes 55: 483-490.
13. Ford N, Mills EJ (2011) Simplified ART Delivery Models Are Needed for the Next Phase of Scale Up. Plos Medicine 8.
14. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, et al. (2004) Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. Aids 18Suppl 3: S27-31.
15. National Department of Health SA (2010) The South African Antiretroviral Treatment Guidelines 2010. Pretoria.
16. Rosenberg PS, (1995) Hazard function estimation using B-splines. Biometrics 51: 874-887.
17. Fewell ZH, MA Wolfe, F Tilling, K Choi, H Sterne, JAC. (2004) Controlling for time-dependent confounding using marginal structural models. The Stata journal: 402-420.
18. Hernan MA, Brumback B, Robins JM, (2000) Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11: 561-570.
19. Hernan MA, Brumback BA, Robins JM, (2002) Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Statistics in medicine 21: 1689-1709.
20. Cole SR, Hernan MA, (2008) Constructing inverse probability weights for marginal structural models. American journal of epidemiology 168: 656-664.
21. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F, (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359: 1173-1177.
22. Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, et al. (2010) Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Current Opinion in Hiv and Aids 5: 298-304.
23. Zachariah R, Harries AD, Philips M, Arnould L, Sabapathy K, et al. (2010) Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Transactions of the Royal Society of Tropical Medicine and Hygiene 104: 387-391.
24. Callaghan M, Ford N, Schneider H (2010) A systematic review of task- shifting for HIV treatment and care in Africa. Human Resources for Health 8.
25. Roura M, Busza J, Wringe A, Mbata D, Urassa M, et al. (2009) Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. AIDS patient care and STDs 23: 203-210.
26. Wringe A, Roura M, Urassa M, Busza J, Athanas V, et al. (2009) Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania. AIDS care 21: 632-637.
27. National Department of Health SA (2008) The South African Antiretroviral Treatment Guidelines. In: Health Do, editor. Pretoria.
28. Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, et al. (2011) Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. The Lancet infectious diseases 11: 942-951.
29. Van Cutsem G, Ford N, Hildebrand K, Goemaere E, Mathee S, et al. (2011) Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS ONE 6: e14684.
30. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, et al. (2009) Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. Journal of acquired immune deficiency syndromes 51: 65-71.